• D Mokart, E Azoulay, D Schnell, A Bourmaud, A Kouatchet, F Pène, V Lemiale, J Lambert, F Bruneel, F Vincent, M Legrand, A Rabbat, and M Darmon.
• Medical-Surgical ICU, Paoli-Calmettes Institute, Marseille, France - mokartd@ipc.unicancer.fr.
• Minerva Anestesiol. 2013 Oct 1;79(10):1156-63.

BackgroundFew studies have evaluated outcomes of neutropenic patients admitted to the ICU at the onset of acute respiratory failure (ARF). The main objective of this study was to describe outcomes and to identify early predictors of hospital mortality in critically ill cancer patients with ARF during chemotherapy-induced neutropenia.MethodsRetrospective analysis of prospectively collected data extracted from two recent prospective multicentre studies. We included neutropenic adults admitted to the ICU for ARF.ResultsOf the 123 study patients, 107 patients (87%) had haematological malignancies; 78 (64%) were male, median age was 57 years (44-62), and median LOD score at ICU admission was 6 (4-9). ICU and hospital mortality rates were 42% and 77%, respectively. Endotracheal mechanical ventilation was an independent risk factor for hospital mortality (odds ratio [OR], 7.73; 95% confidence interval [95%CI], 2.52-23.69); two factors independently protected from hospital mortality, namely, ICU admission for ARF during neutropenia recovery (OR, 0.23; 95%CI, 0.07-0.73) and steroid therapy before ICU admission (OR, 0.35; 95%CI, 0.11-0.95).ConclusionOur study demonstrates a meaningful ICU survival in the studied population and identified factors associated with ICU and hospital mortality. Further work is needed to address the reasons for the high post-ICU mortality rate after ARF.

27 keywords...

hide…